Researchers dig into past records to find best treatment for deadly fungus
NCT ID NCT07191756
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study looks back at medical records of 150 people treated for mucormycosis, a rare but serious fungal infection. Researchers compared two drugs, amphotericin B and isavuconazole, to see which leads to better survival and fewer side effects. The goal is to help doctors choose the best treatment for future patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUCORMYCOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Guangxi Medical University
Nanning, Guangxi, China
Conditions
Explore the condition pages connected to this study.